- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 06.05. | Ichnos Glenmark Innovation (IGI) erhält FDA-Fast-Track-Zulassung für ISB 2001 zur Behandlung des rezidivierten/refraktären multiplen Myeloms | 244 | news aktuell | New York (ots/PRNewswire) - Ergebnisse des Dosis-Eskalationsteils der klinischen Phase-1-Studie mit ISB 2001 bei Patienten mit stark vorbehandeltem multiplem Myelom werden auf der ASCO-Jahrestagung... ► Artikel lesen | |
| 05.05. | Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma | 227 | PR Newswire | Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001 in patients with heavily pretreated multiple myeloma to be presented at the 2025 ASCO Annual Meeting
NEW... ► Artikel lesen | |
| 17.04. | Glenmark Pharma's US arm set to launch generic Adderall tablets | 3 | capitalmarket.com | ||
| 16.04. | Glenmark To Launch Generic Adderall Tablets In May 2025 | 387 | AFX News | WASHINGTON (dpa-AFX) - Glenmark Pharmaceuticals Inc., USA, a wholly owned subsidiary of Glenmark Pharmaceuticals Limited (GLENMARK.NS) Wednesday announced its upcoming May 2025 launch of a generic... ► Artikel lesen | |
| 13.04. | Glenmark, Sun Pharma, Zydus Recall Medicines In US Over Manufacturing Issues | 3 | The Free Press Journal | ||
| 11.04. | Glenmark Pharmaceuticals Ltd slips for fifth straight session | 3 | capitalmarket.com | ||
| 01.04. | Glenmark Launches Vancomycin Hydrochloride For Injection In 3 Doses | 288 | AFX News | NEW DELHI (dpa-AFX) - Glenmark Pharmaceuticals Inc., USA, affiliated to India-based Glenmark Pharmaceuticals Ltd., announced Tuesday the launch of Vancomycin Hydrochloride for Injection USP... ► Artikel lesen | |
| 01.04. | Glenmark launches Vancomycin Hydrochloride for injection USP in the USA | 4 | capitalmarket.com | ||
| 25.03. | Glenmark Pharmaceuticals Ltd: Glenmark Pharmaceuticals Launches Pioneering Nutrition Program to Fight Malnutrition in the Philippines | 289 | PR Newswire | MANILA, Philippines, March 25, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health Futures Foundation... ► Artikel lesen | |
| 21.03. | Glenmark Pharma gains as arm gets USFDA nod for Olopatadine Ophthalmic solution | 3 | capitalmarket.com | ||
| 21.03. | Glenmark Gets FDA Approval For Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) | 417 | AFX News | NEW DELHI (dpa-AFX) - Glenmark Pharmaceuticals Inc., USA announced that it has received final approval from the U.S. Food & Drug Administration (FDA) for its Olopatadine Hydrochloride Ophthalmic... ► Artikel lesen | |
| 21.03. | Stock Alert: Hindustan Unilever, Hindalco Inds, Glenmark Pharma, Ashoka Buildcon | 5 | capitalmarket.com | ||
| 12.03. | Glenmark Pharma launches generic Empagliflozin in India | 4 | capitalmarket.com | ||
| 10.03. | Glenmark Pharma launches osmotic laxative Polyethylene Glycol in US | 2 | capitalmarket.com | ||
| 04.03. | Glenmark issues another recall, this time for nearly 1.5M bottles of generic ADHD drug | 10 | FiercePharma | ||
| 04.03. | Glenmark Pharma launches Acetylcysteine injection in US; long-term positive? | 6 | ZEE Business | ||
| 03.03. | Glenmark Acquires and Launches Acetylcysteine Injection | 2 | Contract Pharma | ||
| 03.03. | Glenmark Pharmaceuticals USA Buys, Launches Acetylcysteine Injection 6 Gm/30 ML Single-Dose Vials | 276 | AFX News | NEW DELHI (dpa-AFX) - Glenmark Pharmaceuticals Inc., USA announces the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL Single-Dose Vials. The company acquired the ANDA for Acetylcysteine... ► Artikel lesen | |
| 03.03. | Glenmark Pharmaceuticals Ltd: Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials | 150 | PR Newswire | MAHWAH, N.J., March 3, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch1 of Acetylcysteine Injection,... ► Artikel lesen | |
| 03.03. | Glenmark Pharma gains after arm launches Acetylcysteine injection | 3 | capitalmarket.com |
Seite:
1 2 3 4 Weiter >>
69 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 2,101 | +0,05 % | Sinopharm Group-Aktie kann Vortagsniveau nicht halten (2,006 €) | Am Aktienmarkt notiert die Sinopharm Group-Aktie gegenwärtig etwas leichter. Das Papier notiert zur Stunde bei 2,01 Euro. Für Inhaber der Sinopharm Group ist der heutige Handelstag bisher nicht sonderlich... ► Artikel lesen | |
| CSPC PHARMA | 0,639 | -3,03 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT WITH CIPLA USA, INC. FOR IRINOTECAN LIPOSOME INJECTION | ||
| WUXI BIOLOGICS | 2,770 | +1,76 % | WuXi Biologics Ireland: Delivering Measurable Sustainability Progress Through Purposeful Innovation | From renewable energy and workforce diversity to local partnerships and sustainable technology, WuXi Biologics' Dundalk site is redefining responsible growth in biomanufacturing.
DUNDALK... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,569 | -2,67 % | FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT REGARDING THE BREAKTHROUGH THERAPY DESIGNATION GRANTED TO PHARMACEUTICAL PRODUCT ... | ||
| GEDEON RICHTER | 25,600 | -2,96 % | Granata Bio Receives Investment From Gedeon Richter | ||
| DR REDDYS | 12,400 | 0,00 % | Dr Reddys Lab jumps after Q4 PAT rises 22% YoY | ||
| ASPEN PHARMACARE | 6,000 | -1,64 % | ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by an Associate of a Director of the Company | ||
| SHANGHAI PHARMACEUTICALS | 1,250 | 0,00 % | SH PHARMA 1Q25 NP Plunges 13.6% YoY to RMB1.333B | ||
| LUYE PHARMA | 0,216 | -1,82 % | LUYE PHARMA (02186): NOTICE OF ANNUAL GENERAL MEETING | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,080 | +11,11 % | SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT THE CLASS 1 INNOVATIVE DRUG BIREOCICLIB TABLETS INDEPENDENTLY DEVELOPED BY XUANZHU BIOPHARMACEUTICAL, AS ... | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,550 | -2,65 % | CHINARES PHARMA (03320): CONTINUING CONNECTED TRANSACTIONS COOPERATION AGREEMENT IN RELATION TO NEW ENERGY PROJECTS | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,790 | -5,95 % | SHINEWAY PHARM (02877): TURNOVER FOR THE FIRST QUARTER OF 2025 | ||
| HANSOH PHARMACEUTICAL | 2,620 | -2,24 % | CLSA Adds Basket Allocation on CSPC PHARMA/HANSOH PHARMA/Hengrui as CN Policy Environment Now More Supportive for Pharmas | ||
| KALBE FARMA | 0,075 | +5,63 % | KLBF potentially distribute 45% to 55% dividend for 2024: KLBF has the potential to distribute 45% to ... | ||
| YICHANG HEC CHANGJIANG PHARMACEUTICAL | - | - | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT MONTHLY UPDATE IN RELATION TO THE PROPOSED PRE-CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL ... |
GLENMARK PHARMACEUTICALS LIMITED gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LIMITED finden Sie auf Wallstreet Online.